World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Biology and Biochemistry 59 12490 11497 5346 4793 248 12951

Tawanda Gumbo publications per year

The chart shows the history of publications by Tawanda Gumbo between 1997 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Tawanda Gumbo published across 29 years, from 1997 to 2025, averaging 8.9 papers a year. Output peaked at 24 publications in 2017. 21 of the 257 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1997 to 2025. Vertical axis: number of publications, 0 to 24. Peak 24 publications in 2017. 1997: 2 publications 1998: 0 publications 1999: 4 publications 2000: 3 publications 2001: 5 publications 2002: 4 publications 2003: 0 publications 2004: 1 publication 2005: 2 publications 2006: 2 publications 2007: 10 publications 2008: 7 publications 2009: 3 publications 2010: 6 publications 2011: 9 publications 2012: 9 publications 2013: 9 publications 2014: 8 publications 2015: 18 publications 2016: 21 publications 2017: 24 publications 2018: 19 publications 2019: 12 publications 2020: 21 publications 2021: 13 publications 2022: 12 publications 2023: 12 publications 2024: 7 publications 2025: 14 publications
1997 2025

257 publications in total across all disciplines

View publications per year as a table
Tawanda Gumbo: publications per year, 1997 to 2025
Year Publications
1997 2
1998 0
1999 4
2000 3
2001 5
2002 4
2003 0
2004 1
2005 2
2006 2
2007 10
2008 7
2009 3
2010 6
2011 9
2012 9
2013 9
2014 8
2015 18
2016 21
2017 24
2018 19
2019 12
2020 21
2021 13
2022 12
2023 12
2024 7
2025 14
Total 257
Download as CSV

Tawanda Gumbo publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Tawanda Gumbo sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 100 bars. Horizontal axis: publications, 47–56 to 1,028+. Vertical axis: number of scientists, 0 to 980. Most scientists, 980, have 127–136 publications. The last bar groups every scientist with 1,028 publications or more. The highlighted bar, 247–256 publications, is where this scientist sits. 47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 413 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 848 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 949 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 840 scientists 207–216 publications: 733 scientists 217–226 publications: 708 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 417 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 196 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 59 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientist 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientist 1,028+ publications: 100 scientists
47–56 publications 1,028+

This scientist: 248 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

View publications distribution as a table
Number of Biology and Biochemistry scientists by publication count, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
Publications Scientists This scientist
47–56 8
57–66 35
67–76 106
77–86 231
87–96 413
97–106 546
107–116 704
117–126 848
127–136 980
137–146 942
147–156 969
157–166 949
167–176 951
177–186 915
187–196 787
197–206 840
207–216 733
217–226 708
227–236 651
237–246 605
247–256 510 248
257–266 524
267–276 434
277–286 417
287–296 350
297–306 363
307–316 315
317–326 296
327–336 261
337–346 240
347–356 219
357–366 196
367–376 154
377–386 161
387–396 155
397–406 145
407–416 124
417–426 112
427–436 132
437–446 116
447–456 99
457–466 81
467–476 91
477–486 80
487–496 80
497–506 59
507–516 36
517–526 46
527–536 54
537–546 44
547–556 43
557–566 43
567–576 42
577–586 25
587–596 34
597–606 23
607–616 33
617–626 31
627–636 27
637–646 25
647–656 28
657–666 34
667–676 18
677–686 16
687–696 10
697–706 12
707–716 21
717–726 12
727–736 12
737–746 10
747–756 7
757–766 13
767–776 15
777–786 13
787–796 9
797–806 9
807–816 7
817–826 4
827–836 9
837–846 7
847–856 3
857–866 5
867–876 5
877–886 11
887–896 3
897–906 4
907–916 7
917–926 5
927–936 6
937–946 6
947–956 3
957–966 7
967–976 2
977–986 2
987–996 1
997–1,006 5
1,007–1,016 2
1,017–1,026 2
1,027 1
1,028+ 100
Download as CSV

Tawanda Gumbo D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Tawanda Gumbo sits on this spectrum.

No. of scientists
250 500 750 1,000 1,250
Bar chart with 65 bars. Horizontal axis: D-Index, 40–41 to 167+. Vertical axis: number of scientists, 0 to 1,253. Most scientists, 1,253, have 58–59 D-Index. The last bar groups every scientist with 167 D-Index or more. The highlighted bar, 58–59 D-Index, is where this scientist sits. 40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 316 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 899 scientists 52–53 D-Index: 1,025 scientists 54–55 D-Index: 1,149 scientists 56–57 D-Index: 1,235 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,162 scientists 62–63 D-Index: 1,130 scientists 64–65 D-Index: 1,031 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 714 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 71 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40–41 D-Index 167+

This scientist: 59 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

View D-Index distribution as a table
Number of Biology and Biochemistry scientists by D-index, Research.com 2026 ranking edition. Based on 19,587 ranked scientists.
D-Index Scientists This scientist
40–41 80
42–43 183
44–45 316
46–47 504
48–49 718
50–51 899
52–53 1,025
54–55 1,149
56–57 1,235
58–59 1,253 59
60–61 1,162
62–63 1,130
64–65 1,031
66–67 897
68–69 814
70–71 714
72–73 709
74–75 596
76–77 512
78–79 473
80–81 412
82–83 373
84–85 358
86–87 285
88–89 273
90–91 227
92–93 208
94–95 193
96–97 153
98–99 157
100–101 148
102–103 120
104–105 113
106–107 100
108–109 86
110–111 67
112–113 71
114–115 73
116–117 64
118–119 53
120–121 60
122–123 54
124–125 43
126–127 38
128–129 49
130–131 26
132–133 18
134–135 23
136–137 32
138–139 32
140–141 27
142–143 19
144–145 22
146–147 12
148–149 16
150–151 14
152–153 10
154–155 13
156–157 10
158–159 7
160–161 9
162–163 13
164–165 4
166 4
167+ 98
Download as CSV

Overview

Tawanda Gumbo is affiliated with Baylor University Medical Center in the United States and has contributed extensively to the field of medicine, with a primary focus on infectious diseases. Their research spans several closely related subfields, including infectious diseases, epidemiology, pharmacology, organic chemistry, and molecular medicine.

Their main topics of research are centered around tuberculosis and associated areas such as Mycobacterium research and diagnosis, antibiotics pharmacokinetics and efficacy, quinazolinone synthesis and applications, antibiotic resistance in bacteria, infectious diseases and tuberculosis, as well as drug transport and resistance mechanisms.

Frequent publication venues for Gumbo include:

  • Antimicrobial Agents and Chemotherapy
  • Frontiers in Pharmacology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Antimicrobial Chemotherapy
  • Open Forum Infectious Diseases

The scientist has authored several recent papers, demonstrating active engagement in tuberculosis-related research. Selected publications include:

  • Dynamic imaging in patients with tuberculosis reveals heterogeneous drug exposures in pulmonary lesions, 2020, Nature Medicine
  • Bacterial and host determinants of cough aerosol culture positivity in patients with drug-resistant versus drug-susceptible tuberculosis, 2020, Nature Medicine
  • Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis, 2021, International Journal of Infectious Diseases
  • Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment, 2022, European Respiratory Journal
  • Omadacycline efficacy in the hollow fibre system model of pulmonary Mycobacterium avium complex and potency at clinically attainable doses, 2022, Journal of Antimicrobial Chemotherapy

Gumbo frequently collaborates with several coauthors, including:

  • Shashikant Srivastava
  • Gunavanthi D. Boorgula
  • Sanjay Singh
  • Devyani Deshpande
  • Jotam G. Pasipanodya

Best Publications

  • Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

    Paul G. Ambrose;Sujata M. Bhavnani;Christopher M. Rubino;Arnold Louie

  • The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

    Keertan Dheda;Tawanda Gumbo;Gary Maartens;Kelly E. Dooley

  • Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes

    Jotam G. Pasipanodya;Helen McIlleron;André Burger;Peter A. Wash

  • Selection of a Moxifloxacin Dose That Suppresses Drug Resistance in Mycobacterium tuberculosis, by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling

    Tawanda Gumbo;Arnold Louie;Mark R. Deziel;Linda M. Parsons

  • Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin

    Tawanda Gumbo;Arnold Louie;Mark R. Deziel;Weiguo Liu

  • Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis.

    Keertan Dheda;Tawanda Gumbo;Neel R Gandhi;Megan Murray

  • Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability

    Shashikant Srivastava;Jotam G. Pasipanodya;Claudia Meek;Richard Leff

  • Meta-Analysis of Clinical Studies Supports the Pharmacokinetic Variability Hypothesis for Acquired Drug Resistance and Failure of Antituberculosis Therapy

    Jotam G. Pasipanodya;Shashikant Srivastava;Tawanda Gumbo

  • Pharmacodynamics of Caspofungin in a Murine Model of Systemic Candidiasis: Importance of Persistence of Caspofungin in Tissues to Understanding Drug Activity

    Arnold Louie;Mark Deziel;Weiguo Liu;Michael F. Drusano

  • Pharmacokinetics-Pharmacodynamics of Pyrazinamide in a Novel In Vitro Model of Tuberculosis for Sterilizing Effect: a Paradigm for Faster Assessment of New Antituberculosis Drugs

    Tawanda Gumbo;Chandima S. W. Siyambalapitiyage Dona;Claudia Meek;Richard Leff

  • The Antibiotic Resistance Arrow of Time: Efflux Pump Induction Is a General First Step in the Evolution of Mycobacterial Drug Resistance

    Aurelia M. Schmalstieg;Shashikant Srivastava;Serkan Belkaya;Devyani Deshpande

  • Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.

    Tawanda Gumbo;Arnold Louie;Weiguo Liu;David Brown

  • Efflux-Pump-Derived Multiple Drug Resistance to Ethambutol Monotherapy in Mycobacterium tuberculosis and the Pharmacokinetics and Pharmacodynamics of Ethambutol

    Shashikant Srivastava;Sandirai Musuka;Carleton Sherman;Claudia Meek

  • New Susceptibility Breakpoints for First-Line Antituberculosis Drugs Based on Antimicrobial Pharmacokinetic/Pharmacodynamic Science and Population Pharmacokinetic Variability

    Tawanda Gumbo

  • A Meta-Analysis of Self-Administered vs Directly Observed Therapy Effect on Microbiologic Failure, Relapse, and Acquired Drug Resistance in Tuberculosis Patients

    Jotam G. Pasipanodya;Tawanda Gumbo

  • Population Pharmacokinetics of Micafungin in Pediatric Patients and Implications for Antifungal Dosing

    William W. Hope;Nita L. Seibel;Cindy L. Schwartz;Antonio Arrieta

  • Intestinal parasites in patients with diarrhea and human immunodeficiency virus infection in Zimbabwe

    Tawanda Gumbo;Steedman Sarbah;Innocent T. Gangaidzo;Ynes Ortega

  • Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis

    Emmanuel Chigutsa;Jotam G. Pasipanodya;Marianne E. Visser;Paul D. van Helden

  • Drug-Penetration Gradients Associated with Acquired Drug Resistance in Patients with Tuberculosis

    Keertan Dheda;Laura Lenders;Gesham Magombedze;Shashikant Srivastava

  • Isoniazid's Bactericidal Activity Ceases because of the Emergence of Resistance, Not Depletion of Mycobacterium tuberculosis in the Log Phase of Growth

    Tawanda Gumbo;Arnold Louie;Weiguo Liu;Paul G. Ambrose

Frequent Co-Authors

Keertan Dheda
Keertan Dheda University of Cape Town
Eric L. Nuermberger
Eric L. Nuermberger Johns Hopkins University
George L. Drusano
George L. Drusano University of Florida
Gary Maartens
Gary Maartens University of Cape Town
Robin M. Warren
Robin M. Warren Stellenbosch University
Soumya Swaminathan
Soumya Swaminathan M S Swaminathan Research Foundation
Johan W. Mouton
Johan W. Mouton Radboud University Medical Center
Sujata M. Bhavnani
Sujata M. Bhavnani University at Buffalo, State University of New York
Dick van Soolingen
Dick van Soolingen National Institute for Public Health and the Environment
Edward K. Wakeland
Edward K. Wakeland The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Biology and Biochemistry in the USA opens doors to diverse career opportunities in healthcare, research, and beyond. Many students use these degrees as a launching pad for further specialized study online, creating flexible and accelerated pathways to professional growth.

For those interested in advanced nursing roles, the shortest online pmhnp certificate programs can qualify graduates to work as psychiatric mental health nurse practitioners. Likewise, aspiring family nurse practitioners can benefit from accredited online fnp programs that streamline licensure and credentialing.

Nutrition is another area closely linked to biology and biochemistry studies. If your interests lie in nutritional science and healthcare, consider pursuing an accelerated nutrition degree online for a fast-track to roles in dietetics or wellness coaching.

Those with a background in nursing may expand their qualifications with practical online rn to bsn programs, combining biological sciences with patient care knowledge.

These online degree options allow students to build on a biology or biochemistry foundation, pursue specialized credentials, and expand their career choices—all with the flexibility of remote learning.

Best Scientists Citing Tawanda Gumbo

Trending Scientists

Recently Published Articles